Novartis A G (NVS)

On  May 27, Reuters reported that Biohub, a philanthropic venture formed by Meta CEO Mark Zuckerberg and Dr. Priscilla Chan, developed a global model of protein biology to speed up drug discovery.

The next frontier of human health may not be found in a hospital; it may be unlocked in a laboratory.

Novartis AG (NYSE:NVS) is one of the best cheap stocks to buy for beginners. Novartis AG (NYSE:NVS) announced on June 3 new Cosentyx® data in polymyalgia rheumatica showing a statistically significant...

On June 2, Ben Snider, chief U.S.

Loomis Sayles, an investment management company, released its “Global Growth Fund” investor letter for the first quarter of 2026.  A copy of the letter is available to download here.

On May 7, NVS began construction on a 46,000-square-foot radioligand therapy manufacturing facility in Denton, Texas.

Pharmaceutical firms have always had a special place in the healthcare market because they provide stability and expansion.

The US economy is navigating a period of heightened volatility, defined by a sharp geopolitical tax on consumers and a resilient but stressed financial sector.

Novartis AG (NYSE:NVS) is one of the best pharma stocks to invest in now.